{"mainPropery":{"diseaseId":9645,"diseaseName":"Human T-cell leukemia virus type 1","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9645/human-t-cell-leukemia-virus-type-1","synonyms":["HTLV-1","Human T lymphotropic virus type 1"],"synonyms-with-source":[{"name":"HTLV-1"},{"name":"Human T lymphotropic virus type 1"}],"identifiers":[]},"diseaseCategories":[{"diseaseTypeId":25,"diseaseTypeName":"Viral infections"}],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=%28htlv%5BTitle%5D%20AND%201%5BTitle%5D%29%20AND%20%22loattrfree%20full%20text%22%5Bsb%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Human T-cell leukemia virus type 1. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Human+T-cell+leukemia+virus+type+1%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Human T-cell leukemia virus type 1. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":553,"resourceId":1305,"resourceName":"HTLV","descriptionText":"Oh U, Jacobson S. <a href='http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610848/?tool=pubmed ' target='_blank'>Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: toward rational targeted therapy</a>. <em>Neurol Clin</em>. 2008 Aug;26(3):781-97, ix-x. ","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1203/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/219285-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1543,"resourceId":2171,"resourceName":"National Cancer Institute","descriptionText":"The <a href='http://www.cancer.gov/dictionary/?CdrID=269419' target='_blank'>National Cancer Institute</a> provides the most current information on cancer for patients, health professionals, and the general public.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"}],"overviewQuestion":{"questionId":7972,"questionText":"What&nbsp;is human T-cell leukemia virus, type 1?","answerText":"<strong>Human T-cell leukemia virus, type 1 (HTLV-1)&nbsp;</strong>is a&nbsp;<a href=\"http://ghr.nlm.nih.gov/glossary=retrovirus\" target=\"_blank\">retroviral</a> infection that affect the T cells (a type of white blood cell). Although this virus generally causes no signs or symptoms, some affected people may later develop <a href=\"http://www.nlm.nih.gov/medlineplus/leukemia.html\" target=\"_blank\">adult T-cell leukemia (ATL)</a>, <a href=\"http://rarediseases.info.nih.gov/gard/8208/htlv-1-associated-myelopathytropical-spastic-paraparesis/resources/1\" target=\"_blank\">HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)</a> or other medical conditions.[7947] HTLV-1 is spread by blood transfusions, sexual contact and sharing needles. It can also be spread from mother to child during birth or breast-feeding. There is no cure or treatment for HTLV-1 and&nbsp;it is&nbsp;considered a lifelong condition; however, most (95%) infected people remain <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002217.htm\" target=\"_blank\">asymptomatic</a> (show no symptoms) throughout life.[7945][7946]","dateModified":"2014-12-10T00:00:00"},"basicQuestions":[{"questionId":7975,"questionText":"What are the signs and symptoms of human T-cell leukemia virus, type 1?","answerText":"Human T-cell leukemia virus, type 1 (HTLV-1)&nbsp;generally causes no signs or symptoms. However, some affected people may later develop <a href=\"http://www.nlm.nih.gov/medlineplus/leukemia.html\" target=\"_blank\">adult T-cell leukemia (ATL)</a>, <a href=\"http://rarediseases.info.nih.gov/gard/8208/htlv-1-associated-myelopathytropical-spastic-paraparesis/resources/1\" target=\"_blank\">HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)</a> or other medical conditions.[7947] <br />\r\n<br />\r\nApproximately 2-5% of people with HTLV-1 will develop ATL, a cancer of the <a href=\"http://www.niaid.nih.gov/topics/immuneSystem/immuneCells/Pages/tcells.aspx\" target=\"_blank\">T-cells</a> (a type of white blood cell). The signs and symptoms of this condition and the disease progression vary from person to person. Affected people may have the following features:[7945][7946]\r\n<ul>\r\n    <li>Fatigue</li>\r\n    <li>Lymphadenopathy (swollen lymph nodes)</li>\r\n    <li>Thirst</li>\r\n    <li>Nausea and vomiting</li>\r\n    <li>Fever</li>\r\n    <li>Skin and bone abnormalities</li>\r\n    <li>Enlarged liver and/or spleen</li>\r\n    <li>Frequent&nbsp;infections</li>\r\n</ul>\r\nRoughly .25-2% of people with HTLV-1 will develop HAM/TSP, a chronic, progressive disease of the nervous system. Signs and symptoms of&nbsp;this condition vary but may include:[7945][7946]\r\n<ul>\r\n    <li>Progressive weakness  </li>\r\n    <li>Stiff muscles  </li>\r\n    <li>Muscle spasms  </li>\r\n    <li>Backache </li>\r\n    <li>'Weak' bladder  </li>\r\n    <li>Constipation </li>\r\n</ul>","dateModified":"2014-12-10T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":7945,"authors":"","articleTitle":"HTLV Type I and Type II","bookWebsiteJournalTitle":"NORD","date":"May 2012","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1203/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7946,"authors":"Ewa Maria Szczypinska, MD","articleTitle":"Human T-Cell Lymphotropic Viruses","bookWebsiteJournalTitle":"Medscape","date":"August 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/219285-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7947,"authors":"David T Scadden, MD; Andrew R Freedman, FRCP; Paul Robertson, MRCP","articleTitle":"Human T-lymphotropic virus type I: Virology, pathogenesis, and epidemiology","bookWebsiteJournalTitle":"UpToDate","date":"June 2014","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7976,"questionText":"What causes human T-cell leukemia virus, type 1?","answerText":"Human T-cell leukemia virus, type 1 (HTLV-1) occurs when a person is infected by the human T-cell leukemia <a href=\"http://ghr.nlm.nih.gov/glossary=retrovirus\" target=\"_blank\">retrovirus</a>. HTLV-1 is spread by blood transfusions, sexual contact and sharing needles.&nbsp;It can also be spread from mother to child during birth or breast-feeding. It is unclear why some people with HTLV-1 develop <a href=\"http://www.nlm.nih.gov/medlineplus/leukemia.html\" target=\"_blank\">adult T-cell leukemia (ATL)</a>, <a href=\"http://rarediseases.info.nih.gov/gard/8208/htlv-1-associated-myelopathytropical-spastic-paraparesis/resources/1\" target=\"_blank\">HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)</a> or other medical conditions, while others remain <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002217.htm\" target=\"_blank\">asymptomatic</a> (show no signs or symptoms)&nbsp;their entire lives.[7945][7946]","dateModified":"2014-12-10T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":7945,"authors":"","articleTitle":"HTLV Type I and Type II","bookWebsiteJournalTitle":"NORD","date":"May 2012","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1203/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7946,"authors":"Ewa Maria Szczypinska, MD","articleTitle":"Human T-Cell Lymphotropic Viruses","bookWebsiteJournalTitle":"Medscape","date":"August 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/219285-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7977,"questionText":"How&nbsp;is human T-cell leukemia virus, type 1 diagnosed?","answerText":"Human T-cell leukemia virus, type 1 (HTLV-1)&nbsp;is usually diagnosed based on blood tests that detect <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002223.htm\" target=\"_blank\">antibodies</a> to the virus. However, HTLV-1 is often never suspected or diagnosed since most people (95%) never develop any signs or symptoms of the infection. Diagnosis may occur during screening for blood donation, testing performed due to a family history of the infection, or a work-up for an HTLV-1-associated condition such as <a href=\"http://www.nlm.nih.gov/medlineplus/leukemia.html\" target=\"_blank\">adult T-cell leukemia (ATL)</a> or <a href=\"http://rarediseases.info.nih.gov/gard/8208/htlv-1-associated-myelopathytropical-spastic-paraparesis/resources/1\" target=\"_blank\">HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)</a>.[7945][7946]","dateModified":"2014-12-10T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":7945,"authors":"","articleTitle":"HTLV Type I and Type II","bookWebsiteJournalTitle":"NORD","date":"May 2012","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1203/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7946,"authors":"Ewa Maria Szczypinska, MD","articleTitle":"Human T-Cell Lymphotropic Viruses","bookWebsiteJournalTitle":"Medscape","date":"August 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/219285-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7978,"questionText":"How&nbsp;might human T-cell leukemia virus, type&nbsp;1 be treated?&nbsp;","answerText":"No cure or treatment exists for human T-cell leukemia virus, type 1 (HTLV-1). Management is focused on early detection and preventing the spread of HTLV-1 to others. Screening blood doners, promoting safe sex and discouraging needle sharing can decrease the number of new infections. Mother-to-child transmission can be reduced by screening pregnant women so infected mothers can avoid breastfeeding.[7948][7945]","dateModified":"2014-12-10T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":7945,"authors":"","articleTitle":"HTLV Type I and Type II","bookWebsiteJournalTitle":"NORD","date":"May 2012","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1203/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7948,"authors":"David T Scadden, MD; Andrew R Freedman, FRCP; Paul Robertson, MRCP","articleTitle":"Human T-lymphotropic virus type I: Disease associations, diagnosis, and treatment","bookWebsiteJournalTitle":"UpToDate","date":"March 2014","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7979,"questionText":"What is the long-term outlook for people with human T-cell leukemia virus, type 1?","answerText":"Ninety-five percent of people with human T-cell leukemia virus, type 1 (HTLV-1) never have any signs of symptoms of the infection and do not go on to develop medical problems. <br />\r\n<br />\r\nApproximately 2 to 5% of infected people will develop <a href=\"http://www.nlm.nih.gov/medlineplus/leukemia.html\" target=\"_blank\">adult T-cell leukemia (ATL)</a>. Depending on the subtype of ATL, people usually live an average of 6 months to 2 years following diagnosis. Although chemotherapy can produce a complete&nbsp;<a href=\"http://www.cancer.gov/dictionary?CdrID=45867\" target=\"_blank\">remission</a>, it does not alter the life expectancy.<br />\r\n<br />\r\nAbout .25 to 2% of people with HTLV-1 infection will develop <a href=\"http://rarediseases.info.nih.gov/gard/8208/htlv-1-associated-myelopathytropical-spastic-paraparesis/resources/1\" target=\"_blank\">HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)</a>.&nbsp;People with HAP/TSP are often unable to walk unassisted within 10 years of onset and need to use a wheelchair within 21 years.[7946]","dateModified":"2014-12-10T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":7946,"authors":"Ewa Maria Szczypinska, MD","articleTitle":"Human T-Cell Lymphotropic Viruses","bookWebsiteJournalTitle":"Medscape","date":"August 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/219285-overview","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":21281,"abbreviatedInquiry":"Is there treatment or a cure for HAM/TSP or for HTLV-1 in general?","caseQuestions":[{"questionId":7978,"questionText":"How&nbsp;might human T-cell leukemia virus, type&nbsp;1 be treated?&nbsp;","answerText":"No cure or treatment exists for human T-cell leukemia virus, type 1 (HTLV-1). Management is focused on early detection and preventing the spread of HTLV-1 to others. Screening blood doners, promoting safe sex and discouraging needle sharing can decrease the number of new infections. Mother-to-child transmission can be reduced by screening pregnant women so infected mothers can avoid breastfeeding.[7948][7945]","dateModified":"2014-12-10T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":7945,"authors":"","articleTitle":"HTLV Type I and Type II","bookWebsiteJournalTitle":"NORD","date":"May 2012","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1203/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7948,"authors":"David T Scadden, MD; Andrew R Freedman, FRCP; Paul Robertson, MRCP","articleTitle":"Human T-lymphotropic virus type I: Disease associations, diagnosis, and treatment","bookWebsiteJournalTitle":"UpToDate","date":"March 2014","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":378,"questionText":"Is there research being conducted on possible treatment options for human T-cell lymphotrophic virus associated myelopathy/tropical spastic paraparesis (HAM/TSP)?","answerText":"The U.S. National Institutes of Health, through the National Library of Medicine, developed <a href=\"http://www.clinicaltrials.gov/\" target=\"_blank\">ClinicalTrials.gov</a> to provide patients, family members, and members of the public with current information on clinical research studies. To find trials enrolling&nbsp;people with HAM/TSP, <a href=\"http://clinicaltrials.gov/ct2/results?term=tropical+spastic+paraparesis\" target=\"_blank\">click here</a>. After you click on a study, review its \"eligibility\" criteria to determine its appropriateness. Use the study&rsquo;s contact information to learn more. Check the ClinicalTrials.gov&nbsp;Web site&nbsp;often for regular updates.<br />\r\n<br />\r\nIf you are interested in enrolling in a clinical trial, you can find helpful general information on clinical trials by <a href=\"http://clinicaltrials.gov/ct2/info/understand\" target=\"_blank\">clicking here</a>. <br />\r\n<br />\r\nA tutorial about clinical trials that can also help answer your questions can be found at the following link from the National Library of Medicine:<br />\r\n<a href=\"http://www.nlm.nih.gov/medlineplus/tutorials/clinicaltrials/htm/video.htm\" target=\"_blank\">http://www.nlm.nih.gov/medlineplus/tutorials/clinicaltrials/htm/video.htm</a><br />","dateModified":"2014-12-01T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Human_T-cell_leukemia_virus_type_1"}